Early inflammatory response in epithelial ovarian tumor cyst fluids. (20th June 2014)

• Record Type: Journal Article
• Authors: Kristjánsdóttir, Björg; Partheen, Karolina; Fung, Eric T.; Yip, Christine; Levan, Kristina; Sundfeldt, Karin
• Is Part Of: Cancer medicine. Volume 3:Number 5(2014:Oct.)
• Page Start: 1302
• Page End: 1312
• Publication Date: 2014-06-20
• Subjects: 616.994005
• DOI: 10.1002/cam4.282
• Languages: English
• ISSNs: 2045-7634

Abstract

<abstract abstract-type="main" id="cam4282-abs-0001"> <title>Abstract</title> <p>Mortality rates for epithelial ovarian cancer (EOC) are high, mainly due to late‐stage diagnosis. The identification of biomarkers for this cancer could contribute to earlier diagnosis and increased survival rates. Given that chronic inflammation plays a central role in cancer initiation and progression, we selected and tested 15 cancer‐related cytokines and growth factors in 38 ovarian cyst fluid samples. We used ovarian cyst fluid since it is found in proximity to the pathology and mined it for inflammatory biomarkers suitable for early detection of EOC. Immunoprecipitation and high‐throughput sample fractionation were obtained by using tandem antibody libraries bead and mass spectrometry. Two proteins, monocyte chemoattractant protein‐1 (MCP‐1/CCL2) and interleucin‐8 (IL‐8/CXCL8), were significantly (<italic>P </italic><<italic> </italic>0.0001) higher in the malignant (<italic>n</italic> = 16) versus benign (<italic>n</italic> = 22) tumor cysts. Validation of MCP‐1, IL‐8, and growth‐regulated protein‐<italic>α</italic> (GRO<italic>α</italic>/CXCL1) was performed with ELISA in benign, borderline, and malignant cyst fluids (<italic>n</italic> = 256) and corresponding serum (<italic>n</italic> = 256). CA125 was measured in serum from all patients and used in the algorithms performed. MCP‐1, IL‐8, and GRO<italic>α</italic> are proinflammatory cytokines and promoters of tumor growth. From 5‐ to 100‐fold higher concentrations of MCP‐1, IL‐8 and GRO<italic>α</italic> were detected in the cyst fluids compared to the serum. Significant (<italic>P</italic> < 0.001) cytokine response was already established in borderline cyst fluids and stage I EOC. In serum a significant (<italic>P</italic> < 0.01) increase of IL‐8 and GRO<italic>α</italic> was found, but not until stage I and stage III EOC, respectively. These findings confirm that early events in tumorigenesis can be analyzed and detected in the tumor environment and we conclude that ovarian cyst fluid is a promising source in the search for new biomarkers for early ovarian tumors.</p> </abstract>